Loading
EI
Endologix Inc /DE/ Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by NEELS GUIDO J, was filed 03 Apr 2019.
Endologix Inc /DE/: what insiders have been doing
Endologix Inc /DE/ is a listed company. Filings by its managers are published through SEC (Form 4). Endologix Inc /DE/ has had no insider filing for more than a year; the last one goes back to 17 September 2020.
Since 2016, the database holds 21 purchases and 34 sales by insiders of the company.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
212
Thresholds
n/a
Buy Volume
€1M
21 ops. · all time
Sell Volume
€620,370
34 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
RevenueUS$127.8M
Gross profitUS$81.2M64% margin
Net income-US$57.7M-45.2% margin
Last declaration on 17 September 2020
Declarations212 total
2,582 shares@ US$0.054.6% of flowCommon StockSEC:0001013606-20-000175:0
33,709 shares@ US$0.050159.9% of flowCommon StockSEC:0001013606-20-000175:1
15,553 shares@ US$0.052128.7% of flowCommon StockSEC:0001013606-20-000175:2
1,126 shares@ US$0.08743.5% of flowCommon StockSEC:0001013606-20-000173:0
1,127 shares@ US$0.08163.3% of flowCommon StockSEC:0001013606-20-000173:1
57,415 shares@ US$0.883583.6% of flowCommon StockSEC:0001013606-20-000170:0
1,306 shares@ US$0.0880.2% of flowCommon StockSEC:0001013606-20-000170:1
30,257 shares@ US$0.08314.1% of flowCommon StockSEC:0001013606-20-000170:2
15,776 shares@ US$0.0855.6% of flowCommon StockSEC:0001013606-20-000168:0
12,088 shares@ US$0.083544.4% of flowCommon StockSEC:0001013606-20-000168:1
12,003 shares@ US$0.08894.5% of flowCommon StockSEC:0001013606-20-000166:0
21,888 shares@ US$0.08815.6% of flowCommon StockSEC:0001013606-20-000167:0
1,628 shares@ US$0.08193.2% of flowCommon StockSEC:0001013606-20-000169:0
113 shares@ US$0.0856.8% of flowCommon StockSEC:0001013606-20-000169:1
28,630 shares@ US$0.083956.3% of flowCommon StockSEC:0001013606-20-000171:0
24,410 shares0Common StockSEC:0001013606-20-000163:0
1,946 shares@ US$0.069817.9% of flowCommon StockSEC:0001013606-20-000149:1
3,417 shares@ US$0.06981.9% of flowCommon StockSEC:0001013606-20-000144:1
891 shares@ US$0.06985.5% of flowCommon StockSEC:0001013606-20-000151:1
9,424 shares@ US$0.06981.1% of flowCommon StockSEC:0001013606-20-000146:1
20,700 shares0Common StockSEC:0001013606-20-000149:0
30,433 shares0Common StockSEC:0001013606-20-000144:0
24,410 shares0Common StockSEC:0001013606-20-000151:0
167,870 shares0Common StockSEC:0001013606-20-000146:0
693 shares@ US$0.848482.1% of flowCommon StockSEC:0001013606-20-000111:1
25 of 212 declarations
About Endologix Inc /DE/
Endologix Inc /DE/ is a NASDAQ-listed company focused on developing medical devices for the treatment of vascular diseases.
